is is too low to expect meaningful benefits for many people, particularly since screening methods are not very precise in identifying people who would benefit from the treatment.In addition, he says, before routine screening, physicians need to consider the potential for harm to people, as no studies have fully analyzed any negative impact from treatment side effects, or misdiagnosis and labelin